The importance of open science continues to grow as digital pathology workflows become increasingly sophisticated and integrated.
Open Science Does Not Require Open Source: The Role of Open Pathology in Research Read More »
Albuquerque, NM, July 30, 2026 – Indica Labs today announces the launch of the HALO® ADC Target Scoring module, a powerful new functionality that supports the development of next-generation precision oncology therapies through quantitative target scoring and spatial analysis.
Albuquerque, NM, May 27, 2026 – Indica Labs, the global leader in AI-powered digital pathology solutions, today announced a major expansion of its companion diagnostics (CDx) capabilities, positioning the company at the forefront of precision medicine innovation ahead of the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.
Indica Labs Unveils AI-Powered Companion Diagnostics Offering Ahead of ASCO 2026 Read More »
Albuquerque, NM, March 3, 2026 – Indica Labs, the global leader in AI-powered digital pathology software and services, today announces surpassing the 3,000th installation of HALO software worldwide.
Check out our flyer to learn more about HALO Clinical AI Solutions
HALO Clinical AI Flyer Read More »
ALBUQUERQUE, NM and TEL AVIV, Israel – May 20, 2021 – Indica Labs, an industry leader in quantitative digital pathology & image management solutions, and Ibex Medical Analytics, a pioneer in artificial intelligence (AI) based cancer diagnostics, announced an agreement to integrate the Ibex™ AI-based cancer diagnostics platform into the HALO AP® digital pathology workflow platform.
